Detalhe da pesquisa
1.
Stereotactic body radiotherapy and tyrosine kinase inhibitors in patients with oligometastatic renal cell carcinoma: a multi-institutional study.
Strahlenther Onkol
; 199(5): 456-464, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450836
2.
Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma.
Urol Int
; 107(2): 171-178, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455527
3.
A new perspective on the future of Turkish Society for Radiation Oncology: Young Radiation Oncologists Group (TROD/GROG 001).
Rep Pract Oncol Radiother
; 28(1): 88-92, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122905
4.
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study.
Strahlenther Onkol
; 198(10): 940-948, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35695908
5.
Clinical parameters and nomograms for predicting lymph node metastasis detected with 68 Ga-PSMA-PET/CT in prostate cancer patients candidate to definitive radiotherapy.
Prostate
; 81(10): 648-656, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33949694
6.
Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.
Prostate
; 81(9): 543-552, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905131
7.
Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 48(11): 3683-3692, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693965
8.
Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002).
Strahlenther Onkol
; 196(11): 1034-1043, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32617620
9.
Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer.
Urol Oncol
; 41(5): 252.e1-252.e8, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36631368
10.
The role of stereotactic body radiotherapy in switching systemic therapy for patients with extracranial oligometastatic renal cell carcinoma.
Clin Transl Oncol
; 24(8): 1533-1541, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35119653
11.
Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.
Radiother Oncol
; 151: 222-227, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861704
12.
In Regard to Fernando et al.: Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Radiother Oncol
; 147: 232, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085932